Dnalite Therapeutics, Inc. logo

Dnalite Therapeutics, Inc.

DNALite Therapeutics, Inc. is a biotechnology company focused on developing prevention and treatment for gastrointestinal diseases.

4

Funding Rounds

$10.4m

Money raised

Overview

DNALite Therapeutics, Inc. is a biotechnology company focused on developing prevention and treatment for gastrointestinal diseases.

Funding series

Funding Series Analysis

The company Dnalite Therapeutics, Inc. has raised a total of $8.93m in funding over 4 rounds.

Key Insights:

  • Dnalite Therapeutics, Inc. Funding Round, April 2022: $8.93m
  • DNAlite Therapeutics Inc funding round, August 2018: $1.5m
Dnalite Therapeutics, Inc. logo
Dnalite Therapeutics, Inc. Funding Round, April 2022 $8.93m
Dnalite Therapeutics, Inc. logo
DNAlite Therapeutics Inc funding round, August 2018 $1.5m